SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining traction as a crypto embodying cannabis culture, community, and freedom. Community members emphasize its focus on positivity, long-term vision, and real-world applications within the cannabis space. The conversation highlights Weedcoin as more than just a token, but as a movement for culture and community.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics is trending due to recent Phase 3 trial data for their skin drug, Sonelokimab, which showed mixed results. While one trial succeeded, another was impacted by a high placebo response, leading to community discussion around potential regulatory implications and future prospects. Community members are actively debating the approvability of the drug, potential buyout scenarios, and comparing it to competitors in the sector.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced private placement, with the community actively discussing whether the stock can sustain its momentum. Some traders believe the financing deal could be dilutive, while others are optimistic about a potential short squeeze given the tight float. Overall, traders are closely monitoring JFB for potential continuation or pullback.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics ($AVTX) is trending due to recent surges in volume and price, sparking speculation about a potential short squeeze or upcoming news catalyst. Community discussions revolve around the possibility of significant upside, comparing it to similar stocks with low floats, while also referencing analyst upgrades and price target increases. The stock's volatility and potential for further gains are key talking points.

Advisorshares Trust - AdvisorShares MSOS 2x Daily ETF

AdvisorShares MSOS Daily Leveraged ETF

MSOX is trending as investors discuss potential catalysts for cannabis stocks, including possible rescheduling and Trump's stance on the industry. Community members are weighing the risks and potential rewards, with some anticipating significant gains while others remain cautious due to the sector's volatility. Bullish sentiment seems to be building amid speculation of upcoming news and a possible short squeeze.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis is trending as community members discuss the potential impact of cannabis rescheduling following supportive comments from former President Trump. Investors are weighing potential benefits like tax relief and uplisting to major exchanges against the risk of political delays. Community members are closely watching for further developments and anticipating a potential surge in the stock price.

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Merus N.V

Merus is trending following news of Genmab's acquisition of the company for $8 billion, or $97 per share, sparking excitement among biotech investors. The community is buzzing about the buyout price and potential implications for other companies in the sector. Some investors are expressing regret for selling their shares earlier, while others are drawing comparisons to similar acquisitions.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Green Thumb Industries is trending as the community discusses the potential impact of cannabis rescheduling following Trump's recent comments and a new $50 million share repurchase program. Community talking points include tax relief, increased profitability for US cannabis companies, and advantages over Canadian competitors. Some investors view GTBIF as a strong, profitable US-based company poised to benefit from regulatory changes.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as traders weigh the potential impacts of a looming government shutdown and speculate on its effects on the market, particularly regarding the release of upcoming jobs data. Community discussions revolve around potential market reactions, with some anticipating a bullish outcome if a shutdown is averted, while others are bracing for volatility and a possible downturn, especially given concerns about high stock valuations and AI-driven market dynamics.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is trending as traders anticipate updates from the company's nomlabofusp clinical development program for Friedreich's ataxia, expected to be released with a conference call. Community discussions revolve around the potential for positive clinical outcomes and speculation regarding leaked data, with some noting unusual options activity and potential for a significant price swing. Bullish sentiment seems to be building.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lam Research Stock Trades at Low P/E: Should You Buy, Sell or Hold?

Despite robust growth in AI and HPC, LRCX faces near-term risks tied to China sales and chip cycle swings.

Applied Optoelectronics (AAOI) Reports Q2 Loss, Misses Revenue Estimates

Applied Optoelectronics (AAOI) delivered earnings and revenue surprises of -100.00% and -1.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

AXT (AXTI) Reports Q2 Loss, Beats Revenue Estimates

AXT (AXTI) delivered earnings and revenue surprises of -15.38% and +0.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Marvell (MRVL): Can Its 7.1% Jump Turn into More Strength?

Marvell (MRVL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Applied Optoelectronics (AAOI) Moves 17.8% Higher: Will This Strength Last?

Optical stocks rise after Nvidia co-packaged optics announcement

Investing.com -- Shares of optical component companies gained in premarket trading after Nvidia (NASDAQ:NVDA) announced plans to implement co-packaged optics (CPO) in its Spectrum X Ethernet and Quantum X Infiniband platforms. 

Shares of Applied Optoelectronics Inc. (AAOI) skyrocketed over 47% during Thursday’s after-hours trade as the company announced the issue of a warrant to Amazon.com Inc. (AMZN) to purchase up to 7.945 million shares.In a filing with the U.S. Securities and Exchange Commission (SEC), Applied Optoelectronics announced that it has entered into a transaction agreement with Amazon.The agreement ties the vesting of shares to a certain value of purchases Amazon should make from the company.In its filing, Applied Optoelectronics revealed that 1.32 million shares have vested on the date of issuance, and the remaining will vest over a period of 10 years, based on discretionary purchases made by Amazon or its affiliates, up to an aggregate of $4 billion.Subject to Amazon’s purchases from the company achieving this milestone, the company has the option to exercise the warrant on or before Mar. 13, 2035, at an exercise price of $23.6954 per share.Applied Optoelectronics’ stock closed Thursday at $15.87.Last week, analysts at B Riley upgraded the company to ‘Neutral’ from ‘Sell’ with a price target of $13.FinChat data shows the average price target for the Applied Optoelectronics stock is $33.50, implying a 111% upside from current levels.Of the five brokerage recommendations, two have ‘Buy’ and ‘Outperform’ ratings, and one recommends investors to ‘Hold’ the stock.Retail sentiment on Stocktwits around the Applied Optoelectronics stock soared, entering the ‘extremely bullish’ (87/100) territory from ‘bearish’ a day ago.<figure class="image"><img style="aspect-ratio:644/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AAOI_retail_sentiment_jpg_91955c84bd.webp" alt="AAOI retail sentiment.jpg" width="644" height="145"><figcaption>AAOI sentiment and message volume March 13, 2025, as of 9 pm ET | Source: Stocktwits</figcaption></figure>Message volumes saw a massive spike, too, hovering at ‘extremely high’ levels at the time of writing.<a href="https://stocktwits.com/symbol/AAOI">Applied Optoelectronics stock</a> has lost nearly 57% of its value year-to-date (YTD), but its one-year performance is relatively better, with&nbsp;a gain of nearly 14%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ondas-stock-tumbles-on-q4-earnings-miss/ch7d4tuRbRn">Ondas Stock Tumbles On Q4 Earnings Miss, Lower-Than-Expected Guidance – But Retail’s Optimistic</a>

Applied Optoelectronics Rips Aftermarket On Issuing Amazon Warrant For Up To 8M Stock Buy — Retail Turns Exuberant

Applied Optoelectronics and Amazon have entered into a transaction agreement that will vest up to 7.945 million shares upon Amazon or its affiliates making discretionary purchases of up to $4 billion from the company.

Equity

Shares of Applied Optoelectronics Inc. (AAOI) rose by over 3% in after-market hours on Tuesday as the company gears up to post fourth-quarter results on Wednesday.According to Stocktwits data, Applied Optoelectronics is expected to report a loss per share of $0.02 in Q4, flipping from earnings per share (EPS) of $0.04 during the same period last year.Applied Optoelectronics is scheduled to post its Q4 results on Wednesday after markets close.However, on a positive note, the fiber optic cable manufacturing company is expected to post revenue of $99.98 million during the quarter, up more than 65% from the same period last year.During the quarter, the Texas-based company also raised $33.7 million in net proceeds via a registered direct offering of equity shares in December. The company said it would use these funds to meet its capital expenditure and other working capital needs.Subsequently, analysts at Raymond James more than doubled their price target for the stock to $39 from $17 – this implies an upside of over 67% from Tuesday’s closing price. The brokerage has an ‘Outperform’ rating on the stock, according to The Fly.FinChat data shows the average price target for the Applied Optoelectronics stock is $34.25, implying a nearly 47% upside from current levels.Of the four brokerage recommendations, two have a ‘Buy’ rating, one has an ‘Outperform’ rating, and one recommends investors to ‘Sell’ the stock.Applied Optoelectronics has missed earnings expectations in two of the last four quarters, but its revenue track record is worse. It missed estimates in three quarters during this period.Retail sentiment on Stocktwits around the Applied Optoelectronics stock gained momentum to hover in the ‘bullish’ (66/100) territory. Message volume was elevated, too, showing increased interest among investors.<figure class="image"><img style="aspect-ratio:647/148;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AAOI_retail_sentiment_f9cf6a02d8.jpg" alt="AAOI retail sentiment.jpg" width="647" height="148"><figcaption>AAOI sentiment and message volume February 26, 2025, as of 2:30 am ET | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/AAOI">Applied Optoelectronics stock</a> has lost nearly 37% of its value year-to-date (YTD), but its one-year performance is far better, with gains of over 58%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nvidia-q4-earnings-expected-to-skyrocket-as-wall-street-expects-ai-boom-to-continue/chdJPy3RUZ">Nvidia Q4 Earnings Expected To Skyrocket As Wall Street Expects AI Boom To Continue: Retail Thinks AI Bellwether Will Save The Market</a>

Fiber optic cable patch panels are located in the data center of a software service provider

Applied Optoelectronics Stock Jumps Ahead Of Q4 Results, Analysts Expect Topline Boost: Retail’s Bullish

In December, the Texas-based company also raised $33.7 million in net proceeds via a registered direct offering of equity shares. The company said it would use these funds to meet its capital expenditure and other working capital needs.

DeepSeek 'likely a head fake', buy the dip says Rosenblatt's Genovese

Investing.com -- Rosenblatt analyst Mike Genovese believes the recent DeepSeek-related sell-off in the optical and Ethernet networking space is “likely a head fake,” urging investors to buy the dip.

Shares of Applied Optoelectronics tumbled over 8% in mid-day trading on Tuesday,&nbsp;to levels last seen on Nov. 20, after B. Riley downgraded the stock.The brokerage revised its rating on the stock to ‘Sell’ from ‘Neutral,’ keeping the price target of $14.&nbsp;B. Riley expressed concerns about a slowdown in demand for 400 Gigabit Ethernet (G) technology, a key revenue driver for AAOI.&nbsp;The brokerage flagged that without qualification of the faster 800G technology by hyperscalers — large-scale cloud service providers — Applied Optoelectronics could struggle to sustain its quarterly revenue of approximately $100 million, most of which currently comes from its cable TV business.The downgrade also highlighted broader market challenges like the shift to 800G requiring significant infrastructure investment, and the IEEE’s ongoing efforts to establish 800G standards suggest it may take time for widespread adoption.&nbsp;Many hyperscale data centers are still transitioning to 400G technology, a mature and proven standard.&nbsp;Meanwhile, competing technologies like 1.6 Terabit Ethernet (1.6T) are already under development, potentially delaying the industry's move to 800G.<figure class="image"><img style="aspect-ratio:641/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_10_142523_f7245fbc7a.png" alt="Screenshot 2024-12-10 142523.png" width="641" height="145"><figcaption>Applied Optoelectronics Sentiment and Message Volume on Dec 10 as of 2:30 p.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock dipped to ‘bearish’ (29/100) from ‘neutral’ a day ago with chatter remaining in the ‘normal’ territory.Some users on Stocktwits anticipated the stock to fall amid increasing volatility and the bearish trend in the broader technology sector due to Nvidia’s regulatory hurdles.<stembedurl>https://stocktwits.com/StockBraker/message/595838149</stembedurl><stembedurl>https://stocktwits.com/jimmywestone317/message/595826162</stembedurl>Despite the day's losses, Applied Optoelectronics remains up nearly 79% year-to-date, reflecting earlier gains from optimism around its technology roadmap.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsmc-stock-dips-on-monthly-revenue-decline-despite-annual-jump/cJa24tIRip">TSMC Stock Slips As Monthly Revenue Declines Despite 34% Annual Jump: Retail Chatter Soars</a>

Workers use microscopes in the production facility at Applied Optoelectronics Tuesday, May 10, 2016, in Houston.  (Photo by Karen Warren/Houston Chronicle via Getty Images)

Applied Optoelectronics Stock Slides To 4-Week Low After Downgrade, Flagging Revenue Risk: Retail Bearish

B. Riley cited concerns over future revenue given falling demand for Applied Optoelectronics’ 400 Gigabit Ethernet and the lack of a green light to proceed with the upgraded 800G technology. 

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

AAOI
Applied Optoelectronics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AAOI News

AAOI Applied Optoelectronics Inc